The company’s pipeline focuses on novel mechanisms with potential best-in-class profiles. As shown in the following comprehensive pipeline overview, Arcus has positioned its assets to address ...
Revolution Medicines Inc (NASDAQ:RVMD) presented its corporate update in August 2025, showcasing significant progress in its RAS inhibitor oncology portfolio. The company’s stock has been volatile ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results